Hua Guo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Tyrosine Kinase

Signaling Pathway

Top Venues

Cell death & disease

Hepatology international

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Dongming Liu, Ran Zuo, Wei Liu, Yuchao He, Yu Wang, Ping Yue, Wenchen Gong, Jinfang Cui, Fu-Yi Zhu, Yi Luo, Lisha Qi, Yan Guo, Liwei Chen, Guangtao Li, Zhiyong Liu, Peng Chen, Hua Guo
DNAJC24 acts directly with PCNA and promotes malignant progression of LUAD by activating phosphorylation of AKT. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (9) (2024)
Dongming Liu, Ran Zuo, Wei Liu, Yuchao He, Yu Wang, Ping Yue, Wenchen Gong, Jinfang Cui, Fu-Yi Zhu, Yi Luo, Lisha Qi, Yan Guo, Liwei Chen, Guangtao Li, Zhiyong Liu, Peng Chen, Hua Guo
DNAJC24 acts directly with PCNA and promotes malignant progression of LUAD by activating phosphorylation of AKT. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (9) (2024)
Wenchen Gong, Su Zhang, Xiangdong Tian, Wenshuai Chen, Yuchao He, Liwei Chen, Tingting Ding, Peiqi Ren, Lin Shi, Qiang Wu, Yan Sun, Lu Chen, Hua Guo
Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular-cholangiocarcinoma. Hepatology international 18 (4) (2024)
Wenchen Gong, Su Zhang, Xiangdong Tian, Wenshuai Chen, Yuchao He, Liwei Chen, Tingting Ding, Peiqi Ren, Lin Shi, Qiang Wu, Yan Sun, Lu Chen, Hua Guo
Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular-cholangiocarcinoma. Hepatology international 18 (4) (2024)
Wenchen Gong, Su Zhang, Xiangdong Tian, Wenshuai Chen, Yuchao He, Liwei Chen, Tingting Ding, Peiqi Ren, Lin Shi, Qiang Wu, Yan Sun, Lu Chen, Hua Guo
Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular-cholangiocarcinoma. Hepatology international (2024)
Na Li, Ran Zuo, Yuchao He, Wenchen Gong, Yu Wang, Liwei Chen, Yi Luo, Cuicui Zhang, Zhiyong Liu, Peng Chen, Hua Guo
PD-L1 induces autophagy and primary resistance to EGFR-TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway. Cell death & disease 15 (8) (2024)
Dongming Liu, Wenshuai Chen, Zhiqiang Han, Yu Wang, Wei Liu, Aomei Ling, Qiang Wu, Huikai Li, Hua Guo
Identification of PANoptosis-relevant subgroups and predicting signature to evaluate the prognosis and immune landscape of patients with biliary tract cancer. Hepatology international (2024)
Na Li, Ran Zuo, Yuchao He, Wenchen Gong, Yu Wang, Liwei Chen, Yi Luo, Cuicui Zhang, Zhiyong Liu, Peng Chen, Hua Guo
PD-L1 induces autophagy and primary resistance to EGFR-TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway. Cell death & disease 15 (8) (2024)
Wenchen Gong, Su Zhang, Xiangdong Tian, Wenshuai Chen, Yuchao He, Liwei Chen, Tingting Ding, Peiqi Ren, Lin Shi, Qiang Wu, Yan Sun, Lu Chen, Hua Guo
Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular-cholangiocarcinoma. Hepatology international 18 (4) (2024)
Na Li, Ran Zuo, Yuchao He, Wenchen Gong, Yu Wang, Liwei Chen, Yi Luo, Cuicui Zhang, Zhiyong Liu, Peng Chen, Hua Guo
PD-L1 induces autophagy and primary resistance to EGFR-TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway. Cell death & disease 15 (8) (2024)
Na Li, Ran Zuo, Yuchao He, Wenchen Gong, Yu Wang, Liwei Chen, Yi Luo, Cuicui Zhang, Zhiyong Liu, Peng Chen, Hua Guo
PD-L1 induces autophagy and primary resistance to EGFR-TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway. Cell death & disease 15 (8) (2024)
Wenchen Gong, Su Zhang, Xiangdong Tian, Wenshuai Chen, Yuchao He, Liwei Chen, Tingting Ding, Peiqi Ren, Lin Shi, Qiang Wu, Yan Sun, Lu Chen, Hua Guo
Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular-cholangiocarcinoma. Hepatology international 18 (4) (2024)
Yuchao He, Linlin Zhan, Jian Shi, Manyu Xiao, Ran Zuo, Chengmeng Wang, Zhiyong Liu, Wenchen Gong, Liwei Chen, Yi Luo, Shaojun Zhang, Youwei Wang, Lu Chen, Hua Guo
The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Yuchao He, Linlin Zhan, Jian Shi, Manyu Xiao, Ran Zuo, Chengmeng Wang, Zhiyong Liu, Wenchen Gong, Liwei Chen, Yi Luo, Shaojun Zhang, Youwei Wang, Lu Chen, Hua Guo
The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Yuchao He, Linlin Zhan, Jian Shi, Manyu Xiao, Ran Zuo, Chengmeng Wang, Zhiyong Liu, Wenchen Gong, Liwei Chen, Yi Luo, Shaojun Zhang, Youwei Wang, Lu Chen, Hua Guo
The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Xiaomeng Hu, Yuchao He, Zhiqiang Han, Wei Liu, Dongming Liu, Xihao Zhang, Lu Chen, Lisha Qi, Liwei Chen, Yi Luo, Qiang Li, Peng Chen, Qiang Wu, Xiaolin Zhu, Hua Guo
PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma. Cell death & disease 13 (11) (2022)
Yafei Wang, Yun Wang, Ruoyan Liu, Chunli Wang, Yi Luo, Liwei Chen, Yuchao He, Keyun Zhu, Hua Guo, Ze Zhang, Jingtao Luo
CAV2 promotes the invasion and metastasis of head and neck squamous cell carcinomas by regulating S100 proteins. Cell death discovery 8 (1) (2022)
Guangtao Li, Yuchao He, Hui Liu, Dongming Liu, Lu Chen, Yi Luo, Liwei Chen, Lisha Qi, Yun Wang, Yingying Wang, Yu Wang, Linlin Zhan, Ning Zhang, Xiaolin Zhu, Tianqiang Song, Hua Guo
DNAJC24 is a potential therapeutic target in hepatocellular carcinoma through affecting ammonia metabolism. Cell death & disease 13 (5) (2022)
Zhiqiang Han, Dongming Liu, Lu Chen, Yuchao He, Xiangdong Tian, Lisha Qi, Liwei Chen, Yi Luo, Ziye Chen, Xiaomeng Hu, Guangtao Li, Linlin Zhan, Yu Wang, Qiang Li, Peng Chen, Zhiyong Liu, Hua Guo
PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway. Cell death & disease 12 (6) (2021)
Dongming Liu, Yi Luo, Lu Chen, Liwei Chen, Duo Zuo, Yueguo Li, Xiaofang Zhang, Jing Wu, Qing Xi, Guangtao Li, Lisha Qi, Xiaofen Yue, Xiehua Zhang, Zhuoyu Sun, Ning Zhang, Tianqiang Song, Wei Lu, Hua Guo
Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study. Cancer biology & medicine 18 (1) (2021)
Yuchao He, Manyu Xiao, Hui Fu, Lu Chen, Lisha Qi, Dongming Liu, Piao Guo, Liwei Chen, Yi Luo, Huiting Xiao, Ning Zhang, Hua Guo
cPLA2α reversibly regulates different subsets of cancer stem cells transformation in cervical cancer. Stem cells (Dayton, Ohio) 38 (4) (2020)
Dongming Liu, Li Lin, Yajie Wang, Lu Chen, Yuchao He, Yi Luo, Lisha Qi, Yan Guo, Liwei Chen, Zhiqiang Han, Guangtao Li, Qiang Li, Zhiyong Liu, Peng Chen, Hua Guo
PNO1, which is negatively regulated by miR-340-5p, promotes lung adenocarcinoma progression through Notch signaling pathway. Oncogenesis 9 (5) (2020)